ClearSight Therapeutics Receives U.S. Patent Notice of Allowance
Oct 14, 2026
DALLAS - Oct. 14, 2026 - PRLog -- ClearSight Therapeutics Receives U.S. Patent Notice of Allowance for Ophthalmic Formulation Technology for unmet ocular diseases
Allowance marks an intellectual property milestone for innovative biopolymeric formulations developed for ocular applications
DALLAS, TX — [Release Date] — ClearSight Therapeutics today announced receipt of a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. 19/380,414, titled "Ophthalmic Solution Containing Quaternary Chitosan Derivatives for Treating Ocular Diseases."
The notice, mailed September 29, 2026, allows 26 claims, including composition and method claims. The allowance represents an important step toward securing U.S. patent protection for ClearSight's ophthalmic formulation technology.
"This allowance marks an important milestone for ClearSight and the science behind our ophthalmic formulations," said Patrick Smale, co-founder and CEO of ClearSight Therapeutics. "Building a strong intellectual property foundation supports our mission to develop innovative, accessible eye care solutions. We're encouraged by this progress as we continue advancing our technology."
"The formulation work focused on preserving the efficacy and key properties of quaternary chitosan in an ophthalmic solution," said co-inventor Nuria Jimenez, PhD, and co-founder & co-inventor Suchismita Acharya, PhD. "We're pleased that the examiner recognized the stability and antiviral activity data presented in the application, and we look forward to building on this scientific foundation to develop our eyedrop product to help people and expand our patent portfolio."
In its statement of reasons for allowance, the examiner cited evidence of acceptable formulation stability, preserved antiviral activity, and unexpectedly higher antiviral activity at 8- and 24-hour time points. These findings relate to evidence presented during patent examination and do not establish clinical efficacy or regulatory approval.
About ClearSight Therapeutics
ClearSight Therapeutics is a Dallas/Fort Worth-based company founded in 2023 by eye care industry veterans and partners to develop better solutions for common eye conditions. The company is advancing next-generation over-the-counter ophthalmic products designed to address dryness, irritation, and ocular discomfort. For more information, visit clearsighttx.com.
Media Contact
ClearSight Therapeutics
[email protected]
972-983-7761
Photos: (Click photo to enlarge)
Source: ClearSight Therapeutics, Inc.
Read Full Story - ClearSight Therapeutics Receives U.S. Patent Notice of Allowance | More news from this source
Press release distribution by PRLog
More News
Public Colleges Are Passing the $50,000-a-Year Mark. For Locals.
At the University of California campuses in Berkeley, Irvine and Santa Barbara, students get an unwitting education in navigating the housing market.
Budget to include £1bn for social and affordable housing
The move will take funding for the 10-year programme to more than £40bn.
My Co-Worker Is Losing It Over My Religion
Plus: Reader responses to a woman returning to the office after two decades of self-employment.
The Long Life of the ‘Snacking Occasion’
As eating habits shift, the food industry is promoting any opportunity to nibble.
Rosebank: Life on the oil field at the centre of a political storm
Scotland editor James Cook finds out what life is like on board a ship in an untapped oil field awaiting its fate.
Heating oil costs 'more than double' ahead of winter
Middleton in Teesdale has no mains gas supply so many residents use expensive heating oil.
How families are cutting the cost of Halloween as spending grows
Families are turning to homemade costumes, swaps and second-hand outfits to keep it affordable.
Firms 'holding back' on new jobs ahead of Budget
Some businesses say they want to see employment costs come down in the October Budget.
Will a new code end 'rip-off parking charges'?
The prime minister says a new code will end "rip-off parking charges" - but will it work?
Budget 2026: No more fat to trim for 'squeezed middle'
As the chancellor finalises his first Budget, how are the "squeezed middle" feeling about costs?
Four ways Labour could raise money in the Budget without hiking income tax
Chancellor John Healey may need to raise money to boost his fiscal headroom - BBC Verify examines what options could be on the table.
For Clues About How A.I. Will Change Work, Look to the Past
Economists hope earlier episodes of labor disruption, from the Industrial Revolution to the Great Depression, can help us prepare for the age of artificial intelligence.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.